是罗氏的试验模型不一样?还是真比·其他几个好?PD-L1阳性响应率为26%,PD-L1阴性9.5%
回答: 我们Roche的免疫治疗PD-L1药物Atezolizumab在二线NSCLC显现出对所有病人都工作, 不管PD-L1expre
由 riverflow2017
于 2017-08-31 20:11:21
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2025 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy